Ani Pharmaceuticals (ANIP) Other Working Capital Changes (2010 - 2013)
Ani Pharmaceuticals (ANIP) reported Other Working Capital Changes of -$100928.0 for Q1 2013, down 19.83% on a YoY basis from -$125890.2 in Q1 2012, and up 40.44% sequentially from -$169445.0 in Q4 2012.
Ani Pharmaceuticals (ANIP) Other Working Capital Changes (2010 - 2013) Analysis & Trends
Ani Pharmaceuticals (ANIP) has 4 years of Other Working Capital Changes data on file, last reported at -$100928.0 in Q1 2013.
- For the quarter ending Q1 2013, Other Working Capital Changes fell 19.83% year-over-year to -$100928.0; the trailing twelve-month figure through Mar 2013 stood at -$509371.0 (down 17.27% YoY), and the FY2012 full-year result was -$492670.0, up 70.72% from the prior year.
- Other Working Capital Changes advanced to -$100928.0 in Q1 2013, from -$169445.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $1.3 million in Q4 2010 to a low of -$1.3 million in Q1 2011.
- A 4-year average of -$72502.6 and a median of -$100928.0 in 2013 frame the typical range for Other Working Capital Changes.
- Across the five-year window, Other Working Capital Changes tumbled 143.65% in 2011 and jumped 93.68% in 2012, its largest moves.
- Tracing ANIP's Other Working Capital Changes over 4 years: stood at $1.3 million in 2010, then tumbled by 110.81% to -$142563.0 in 2011, then fell by 18.86% to -$169445.0 in 2012, then surged by 40.44% to -$100928.0 in 2013.
- Business Quant data shows ANIP's Other Working Capital Changes at -$100928.0 in Q1 2013, -$169445.0 in Q4 2012, and -$37308.0 in Q3 2012.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Ani Pharmaceuticals | 1.64 Bn | 1.33 Bn | 143.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2013 | -100,928.00 |
| Mar 31, 2013 | -100,928.00 |
| Mar 31, 2013 | -100,928.00 |
| Dec 31, 2012 | -169,445.00 |
| Dec 31, 2012 | -169,445.00 |
| Dec 31, 2012 | -169,445.00 |
| Sep 30, 2012 | -37,308.00 |
| Sep 30, 2012 | -37,308.00 |
| Sep 30, 2012 | -37,308.00 |
| Jun 30, 2012 | -201,690.00 |
| Jun 30, 2012 | -201,690.00 |
| Jun 30, 2012 | -201,690.00 |
| Mar 31, 2012 | -84,227.00 |
| Mar 31, 2012 | -84,227.00 |
| Mar 31, 2012 | -84,227.00 |
| Dec 31, 2011 | -142,563.00 |
| Dec 31, 2011 | -142,563.00 |
| Dec 31, 2011 | -142,563.00 |
| Sep 30, 2011 | -69,605.00 |
| Sep 30, 2011 | -69,605.00 |